Akèy › Kadyomiopati › Oregon
Etid klinik pou Kadyomiopati nan Oregon
4 etid pou Kadyomiopati ap chèche patisipan nan sit nan Oregon.
Vil nan Oregon
Tèks ofisyèl etid la (Anglè)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Portland
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903Clinical Course Of Disease In Participants With FA-CM
- Oregon Health & Science University, Portland
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06865482Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Oregon Health & Science University, Portland
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Oregon Health and Science University (OHSU), Portland
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.